| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c828bbae1a451567c7130a725cd65a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_275db03e52f8c59619073b86f42b0fa8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2018-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dd6b803930bad68def0f48887941497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f0d872045c4b7ab16499481a188771e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b9d2a8e1860c61574d6fbefc5cac5a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_addc1a5e6eb794f9757ad5dfa2eba489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f2caefb5ae80f0c6acbeb855e7b301f |
| publicationDate |
2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019343906-A1 |
| titleOfInvention |
Tablet of sporoderm-removed ganoderma lucidum spore and preparation method thereof |
| abstract |
The present invention provides a tablet of sporoderm-removed Ganoderma lucidum spore, which includes the following raw materials by weight parts: 13-20 parts of an aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, 3-5 parts of sorbitol, and 0.8-1.2 parts of povidone K30; A method for preparing the tablet of sporoderm-removed Ganoderma lucidum spore includes the following steps: mixing the aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, sorbitol and povidone K30 for 10-30 min, and subjecting the obtained mixture to granulating, screening and drying to obtain a granular material; and tableting the granular material to obtain the tablet of sporoderm-removed Ganoderma lucidum spore. The tablet of sporoderm-removed Ganoderma lucidum spore has a much higher content of active components, which are also easier to be absorbed. The tablet of sporoderm-removed Ganoderma lucidum spore is of effectively enhancing the body immunity and have anti-radiation and anti-tumor effects; and the dosage form of the tablet is convenient to carry and take. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113081978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022103901-A1 |
| priorityDate |
2017-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |